Efficient adult skeletal muscle regeneration in mice deficient in p38β, p38γ and p38δ MAP kinases

Cell Cycle

Volumn 7, Issue 14, 2008, Pages 2208-2214

  Ruiz Bonilla, Vanessa ^a,b   Perdiguero, Eusebio ^a,b   Gresh, Lionel ^c,d   Serrano, Antonio L ^a,b   Zamora, Mònica ^a,b   Sousa Victor, Pedro ^a,b   Jardí, Mercè ^a,b   Wagner, Erwin F ^c,d   Muñoz Cánoves, Pura ^a,b,e  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

^e CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

Knockout mice; Muscle regeneration; Myogenesis; p38 MAP Kinases; p38beta; p38delta; p38gamma; Satellite cell; Skeletal muscle

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 11; MITOGEN ACTIVATED PROTEIN KINASE 12; MITOGEN ACTIVATED PROTEIN KINASE 13;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYOTOXICITY; ENZYME DEFICIENCY; EXPERIMENTAL MOUSE; IN VITRO STUDY; MAMMAL CELL; MOUSE; MUSCLE DEVELOPMENT; MUSCLE GROWTH; MUSCLE REGENERATION; MYOBLAST; NEWBORN; NONHUMAN; PROTEIN FUNCTION; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; WILD TYPE;

MAMMALIA; MUS;

EID: 47749146499     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.14.6273     Document Type: Article

References (41)

1. Keren A, Tamir Y, Bengal E. The p38 MAPK signaling pathway: A major regulator of skeletal muscle development. Mol Cell Endocrinol 2006; 288:73-86.
2. Forcales SV, Puri PL. Signaling to the chromatin during skeletal myogenesis: novel targets for pharmacological modulation of gene expression. Semin Cell Dev Biol 2005; 16:596-611.
3. Lluis F, Perdiguero E, Nebreda AR, Munoz-Canoves P. Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol 2006; 16:36-44.
4. Nebreda AR, Porras A. p38 MAP kinases: beyond the stress response. Trends Biochem Sci 2000; 25:257-60.
5. Kyriakis JM. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001; 81:807-69.
6. Bradham C, McClay DR. p38 MAPK in development and cancer. Cell Cycle 2006; 5:824-8.
7. Pimienta G, Pascual J. Canonical and alternative MAPK signaling. Cell Cycle 2007; 6:2628-32.
8. Zhao M, New L, Kravchenko VV, Kato Y, Gram H, Di Padova F, Olson EN, Ulevitch RJ, Han J. Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol 1999; 19:21-30.
9. Zetser A, Gredinger E, Bengal E. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J Biol Chem 1999; 274:5193-200.
10. Wu Z, Woodring P, Bhakta K, Tamura K, Wen F, Feramisco JR, Karin M, Wang JY, Puri PL. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Molecular and Cellular Biology 2000; 20:3951-64.
11. Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella L, Puri PL. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat Genet 2004; 36:738-43.
12. Lluis F, Ballestar E, Suelves M, Esteller M, Munoz-Canoves P. E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription. Embo J 2005; 24:974-84.
13. Rampalli S, Li L, Mak E, Ge K, Brand M, Tapscott SJ, Dilworth FJ. p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat Struct Mol Biol 2007; 14:1150-6.
14. Serra C, Palacios D, Mozzetta C, Forcales SV, Morantte I, Ripani M, Jones DR, Du K, Jhala US, Simone C, Puri PL. Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation. Mol Cell 2007; 28:200-13.
15. Briata P, Forcales SV, Ponassi M, Corte G, Chen CY, Karin M, Puri PL, Gherzi R. p38-Dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts. Mol Cell 2005; 20:891-903.
16. Cuenda A, Cohen P. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J Biol Chem 1999; 274:4341-6.
17. Li Y, Jiang B, Ensign WY, Vogt PK, Han J. Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase. Cell Signal 2000; 12:751-7.
18. de Angelis L, Zhao J, Andreucci JJ, Olson EN, Cossu G, McDermott JC. Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2 signaling pathway. Dev Biol 2005; 283:171-9.
19. Keren A, Bengal E, Frank D. p38 MAP kinase regulates the expression of XMyf5 and affects distinct myogenic programs during Xenopus development. Dev Biol 2005; 288:73-86.
20. Perdiguero E, Ruiz-Bonilla V, Gresh L, Hui L, Ballestar E, Sousa-Victor P, Baeza-Raja B, Jardi M, Bosch-Comas A, Esteller M, Caelles C, Serrano AL, Wagner EF, Munoz-Canoves P. Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation. Embo J 2007; 7:1245-56.
21. Kassar-Duchossoy L, Gayraud-Morel B, Gomes D, Rocancourt D, Buckingham M, Shinin V, Tajbakhsh S. Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice. Nature 2004; 431:466-71.
22. Tajbakhsh S. Skeletal muscle stem and progenitor cells: reconciling genetics and lineage. Exp Cell Res 2005; 306:364-72.
23. Sartorelli V, Caretti G. Mechanisms underlying the transcriptional regulation of skeletal myogenesis. Curr Opin Genet Dev 2005; 15:528-35.
24. Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, Perez L, Klein R, Nebreda AR. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 2000; 6:109-16.
25. Tamura K, Sudo T, Senftleben U, Dadak AM, Johnson R, Karin M. Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 2000; 102:221-31.
26. Mudgett JS, Ding J, Guh-Siesel L, Chartrain NA, Yang L, Gopal S, Shen MM. Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci USA 2000; 97:10454-9.
27. Hui L, Bakiri L, Mairhorfer A, Schweifer N, Haslinger C, Kenner L, Komnenovic V, Scheuch H, Beug H, Wagner EF. p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat Genet 2007; 30:741-49.
28. Beardmore VA, Hinton HJ, Eftychi C, Apostolaki M, Armaka M, Darragh J, McIlrath J, Carr JM, Armit LJ, Clacher C, Malone L, Kollias G, Arthur JS. Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol Cell Biol 2005; 25:10454-64.
29. Kim JM, White JM, Shaw AS, Sleckman BP. MAPK p38alpha is dispensable for lymphocyte development and proliferation. J Immunol 2005; 174:1239-44.
30. Sabio G, Arthur JS, Kuma Y, Peggie M, Carr J, Murray-Tait V, Centeno F, Goedert M, Morrice NA, Cuenda A. p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. Embo J 2005; 24:1134-45.
31. Aronson D, Wojtaszewski JF, Thorell A, Nygren J, Zangen D, Richter EA, Ljungqvist O, Fielding RA, Goodyear LJ. Extracellular-regulated protein kinase cascades are activated in response to injury in human skeletal muscle. Am J Physiol 1998; 275:555-61.
32. Boppart MD, Asp S, Wojtaszewski J F, Fielding RA, Mohr T, Goodyear LJ. Marathon running transiently increases c-Jun NH2-terminal kinase and p38 activities in human skeletal muscle. J Physiol 2000; 526:663-9.
33. Tortorella LL, Lin CB, Pilch PF. ERK6 is expressed in a developmentally regulated manner in rodent skeletal muscle. Biochem Biophys Res Commun 2003; 306:163-8.
34. Hui L, Bakiri L, Stepniak E, Wagner EF. p38alpha: A Suppressor of Cell Proliferation and Tumorigenesis. Cell Cycle 2007; 6:2429-33.
35. Perdiguero E, Ruiz-Bonilla V, Serrano AL, Munoz-Canoves P. Genetic deficiency of p38alpha reveals its critical role in myoblast cell cycle exit: the p38alpha-JNK connection. Cell Cycle 2007; 6:1298-303.
36. Askari N, Diskin R, Avitzour M, Capone R, Livnah O, Engelberg D. Hyperactive variants of p38alpha induce, whereas hyperactive variants of p38gamma suppress, activating protein 1-mediated transcription. J Biol Chem 2007; 282:91-9.
37. Qi X, Pohl NM, Loesch M, Hou S, Li R, Qin JZ, Cuenda A, Chen G. p38alpha antagonizes p38gamma activity through c-Jun-dependent ubiquitin-proteasome pathways in regulating Ras transformation and stress response. J Biol Chem 2007; 282:31398-408.
38. Wang. Involvement of the p38 Mitogen-activated Protein Kinase {alpha}, {beta}, and {gamma} Isoforms in Myogenic Differentiation. Mol Biol Cell 2008; 19:1519-28.
39. Suelves M, Lluis F, Ruiz V, Nebreda AR, Munoz-Canoves P. Phosphorylation of MRF4 transactivation domain by p38 mediates repression of specific myogenic genes. Embo J 2004; 23:365-75.
40. Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M, Munoz-Canoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 2008; 7:33-44.
41. Suelves M, Vidal B, Serrano AL, Tjwa M, Roma J, Lopez-Alemany R, Luttun A, de Lagran MM, Diaz-Ramos A, Jardi M, Roig M, Dierssen M, Dewerchin M, Carmeliet P, Munoz-Canoves P. uPA deficiency exacerbates muscular dystrophy in MDX mice. J Cell Biol 2007; 178:1039-51.